ALBAN CARLOS
Insider CIK 1474632 · ABBV Vice Chairman · SWTX Director · ABT Senior Vice President · SOLV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SOLV Solventum Corp | A Award deriv | 2026-05-15 | 2026-05-18 | 3,300 | — | $0 | 3,300 | SEC↗ |
| SOLV Solventum Corp | M Exercise deriv | 2026-04-30 | 2026-05-01 | 3,403 | — | $0 | 0 | SEC↗ |
| SOLV Solventum Corp | M Exercise | 2026-04-30 | 2026-05-01 | 3,403 | — | $0 | 8,947 | SEC↗ |
| SOLV Solventum Corp | M Exercise deriv | 2026-03-27 | 2026-03-30 | 1,980 | — | $0 | 0 | SEC↗ |
| SOLV Solventum Corp | M Exercise | 2026-03-27 | 2026-03-30 | 1,980 | — | $0 | 5,544 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 30,160 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 13,774 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 12,216 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer | 2025-07-01 | 2025-07-02 | 28,861 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 28,861 | SEC↗ |
| SOLV Solventum Corp | M Exercise deriv | 2025-05-13 | 2025-05-15 | 3,564 | — | $0 | 0 | SEC↗ |
| SOLV Solventum Corp | M Exercise | 2025-05-13 | 2025-05-15 | 3,564 | — | $0 | 3,564 | SEC↗ |
| SOLV Solventum Corp | A Award deriv | 2025-04-30 | 2025-05-02 | 3,403 | — | $0 | 3,403 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2024-05-16 | 2024-05-17 | 12,216 | — | $0 | 12,216 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2024-05-16 | 2024-05-17 | 4,095 | — | $0 | 18,801 | SEC↗ |
| SOLV Solventum Corp | A Award deriv | 2024-05-13 | 2024-05-15 | 1,980 | — | $0 | 5,544 | SEC↗ |
| SOLV Solventum Corp | A Award deriv | 2024-05-13 | 2024-05-15 | 3,564 | — | $0 | 3,564 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2023-05-24 | 2023-05-25 | 13,774 | — | $0 | 13,774 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2023-05-24 | 2023-05-25 | 4,648 | — | $0 | 14,706 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-07-14 | 2022-07-15 | 30,160 | — | $0 | 30,160 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-07-14 | 2022-07-15 | 10,058 | — | $0 | 10,058 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2020-11-16 | 2020-11-18 | 115,830 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2020-11-16 | 2020-11-18 | 115,830 | $100.00 | $11.58M | 114,899 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2020-11-16 | 2020-11-18 | 115,830 | $35.88 | $4.16M | 230,729 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2020-07-07 | 2020-07-08 | 23,000 | $100.00 | $2.30M | 114,899 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2020-07-07 | 2020-07-08 | 30,325 | $100.00 | $3.03M | 137,899 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2020-02-28 | 2020-03-03 | 32,092 | $85.42 | $2.74M | 168,224 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2020-02-20 | 2020-02-24 | 114,566 | — | $0 | 114,566 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 39,760 | — | $0 | 167,637 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 10,125 | — | $0 | 200,316 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 14,340 | — | $0 | 181,977 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2020-02-20 | 2020-02-24 | 8,214 | — | $0 | 190,191 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2019-02-28 | 2019-03-04 | 24,125 | $79.41 | $1.92M | 127,877 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2019-02-21 | 2019-02-22 | 62,305 | — | $0 | 62,305 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 18,545 | — | $0 | 116,097 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 13,350 | — | $0 | 129,447 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 8,215 | — | $0 | 152,002 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2019-02-21 | 2019-02-22 | 14,340 | — | $0 | 143,787 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2018-03-01 | 2018-03-02 | 48,100 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2018-03-01 | 2018-03-02 | 14,829 | $114.43 | $1.70M | 97,552 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2018-03-01 | 2018-03-02 | 46,997 | $114.63 | $5.39M | 112,381 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2018-03-01 | 2018-03-02 | 19,169 | $113.75 | $2.18M | 159,378 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2018-03-01 | 2018-03-02 | 48,100 | $29.23 | $1.41M | 178,547 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2018-02-28 | 2018-03-02 | 2,579 | $117.85 | $303.9K | 130,447 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2018-02-28 | 2018-03-02 | 25,976 | $118.26 | $3.07M | 133,026 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2018-02-15 | 2018-02-16 | 44,430 | — | $0 | 44,430 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 13,350 | — | $0 | 128,950 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 14,340 | — | $0 | 159,002 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2018-02-15 | 2018-02-16 | 16,567 | — | $0 | 144,662 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2017-06-14 | 2017-06-15 | 45,800 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2017-06-14 | 2017-06-15 | 45,800 | $24.21 | $1.11M | 160,545 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-06-14 | 2017-06-15 | 45,800 | $70.00 | $3.21M | 114,745 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2017-05-04 | 2017-05-08 | 43,000 | $67.00 | $2.88M | 114,745 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2017-02-28 | 2017-03-02 | 34,721 | $62.22 | $2.16M | 157,745 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2017-02-16 | 2017-02-21 | 95,750 | — | $0 | 95,750 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2017-02-16 | 2017-02-21 | 13,350 | — | $0 | 192,466 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2017-02-16 | 2017-02-21 | 29,672 | — | $0 | 179,116 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2016-05-10 | 2016-05-12 | 47,438 | $63.52 | $3.01M | 149,444 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2016-02-29 | 2016-03-02 | 39,930 | $56.00 | $2.24M | 196,882 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2016-02-18 | 2016-02-22 | 79,870 | — | $0 | 79,870 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2015-02-28 | 2015-03-03 | 7,200 | $60.50 | $435.6K | 236,812 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2015-02-27 | 2015-03-03 | 12,706 | $60.52 | $769.0K | 244,012 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2015-02-19 | 2015-02-23 | 101,960 | — | $0 | 101,960 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2015-02-19 | 2015-02-23 | 51,580 | — | $0 | 256,718 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 1,600 | $50.09 | $80.1K | 206,420 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 282 | $50.09 | $14.1K | 206,138 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 400 | $50.09 | $20.0K | 205,738 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2014-03-03 | 2014-03-04 | 600 | $50.09 | $30.1K | 205,138 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2014-02-28 | 2014-03-04 | 15,319 | $50.91 | $779.9K | 208,020 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2014-02-20 | 2014-02-24 | 81,500 | — | $0 | 81,500 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2014-02-20 | 2014-02-24 | 47,260 | — | $0 | 223,339 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-05-01 | 2013-05-03 | 17,700 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-05-01 | 2013-05-03 | 34,600 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-05-01 | 2013-05-03 | 35,700 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-05-01 | 2013-05-03 | 21,000 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-05-01 | 2013-05-03 | 33,900 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-05-01 | 2013-05-03 | 28,122 | $45.68 | $1.28M | 261,613 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-05-01 | 2013-05-03 | 35,700 | $27.29 | $974.3K | 182,535 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-05-01 | 2013-05-03 | 33,900 | $28.86 | $978.4K | 216,435 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-05-01 | 2013-05-03 | 17,700 | $28.13 | $497.9K | 234,135 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-05-01 | 2013-05-03 | 27,664 | $45.68 | $1.26M | 176,079 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-05-01 | 2013-05-03 | 30,550 | $45.68 | $1.40M | 203,743 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2013-05-01 | 2013-05-03 | 27,320 | $45.66 | $1.25M | 234,293 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-05-01 | 2013-05-03 | 34,600 | $28.31 | $979.5K | 289,735 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-05-01 | 2013-05-03 | 21,000 | $26.85 | $563.9K | 255,135 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-02-28 | 2013-03-04 | 12,960 | $36.73 | $476.0K | 146,835 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-02-19 | 2013-02-19 | 9,826 | $37.58 | $369.3K | 159,795 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2013-02-14 | 2013-02-19 | 115,830 | — | $0 | 115,830 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2013-02-14 | 2013-02-19 | 56,700 | — | $0 | 169,621 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2013-02-05 | 2013-02-07 | 2,482 | — | $0 | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2013-02-05 | 2013-02-07 | 2,482 | $33.80 | $83.9K | 115,246 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2013-02-05 | 2013-02-07 | 2,325 | $37.28 | $86.7K | 112,921 | SEC↗ |
| ABT ABBOTT LABORATORIES | A Award | 2012-12-01 | 2012-12-04 | 18,453 | — | $0 | 95,696 | SEC↗ |
| ABT ABBOTT LABORATORIES | G Gift | 2012-11-16 | 2012-12-04 | 40,442 | — | $0 | 77,243 | SEC↗ |
| ABT ABBOTT LABORATORIES | G Gift | 2012-11-16 | 2012-12-04 | 40,442 | — | $0 | 40,442 | SEC↗ |
| ABT ABBOTT LABORATORIES | F Tax w/h | 2012-10-15 | 2012-10-17 | 2,032 | $69.28 | $140.8K | 117,685 | SEC↗ |
| ABT ABBOTT LABORATORIES | A Award | 2012-10-15 | 2012-10-17 | 4,900 | — | $0 | 119,717 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise deriv | 2012-09-25 | 2012-09-27 | 1,198 | — | $0 | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise | 2012-09-25 | 2012-09-27 | 1,198 | $57.25 | $68.6K | 116,015 | SEC↗ |
| ABT ABBOTT LABORATORIES | S Sale | 2012-09-25 | 2012-09-27 | 1,198 | $70.00 | $83.9K | 114,817 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise deriv | 2012-09-20 | 2012-09-21 | 1,918 | — | $0 | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | S Sale | 2012-09-20 | 2012-09-21 | 1,918 | $69.75 | $133.8K | 114,817 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise | 2012-09-20 | 2012-09-21 | 1,918 | $56.98 | $109.3K | 116,735 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise deriv | 2012-09-13 | 2012-09-17 | 1,331 | — | $0 | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | S Sale | 2012-09-13 | 2012-09-17 | 1,331 | $68.75 | $91.5K | 114,817 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise | 2012-09-13 | 2012-09-17 | 1,331 | $56.00 | $74.5K | 116,148 | SEC↗ |
| ABT ABBOTT LABORATORIES | S Sale | 2012-07-30 | 2012-08-01 | 352 | $66.62 | $23.5K | 114,817 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise deriv | 2012-07-27 | 2012-07-30 | 30,800 | — | $0 | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise deriv | 2012-07-27 | 2012-07-30 | 5,200 | — | $0 | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise deriv | 2012-07-27 | 2012-07-30 | 7,299 | — | $0 | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise deriv | 2012-07-27 | 2012-07-30 | 1,538 | — | $0 | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | S Sale | 2012-07-27 | 2012-07-30 | 43,299 | $65.00 | $2.81M | 116,707 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise | 2012-07-27 | 2012-07-30 | 1,538 | $56.98 | $87.6K | 160,006 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise | 2012-07-27 | 2012-07-30 | 5,200 | $44.16 | $229.6K | 127,668 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise | 2012-07-27 | 2012-07-30 | 7,299 | $46.34 | $338.2K | 122,468 | SEC↗ |
| ABT ABBOTT LABORATORIES | S Sale | 2012-07-27 | 2012-07-30 | 1,538 | $66.00 | $101.5K | 115,169 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise | 2012-07-27 | 2012-07-30 | 30,800 | $41.48 | $1.28M | 158,468 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise deriv | 2012-07-23 | 2012-07-25 | 2,601 | — | $0 | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | A Award deriv | 2012-07-23 | 2012-07-25 | 2,482 | — | $0 | 2,482 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise deriv | 2012-07-23 | 2012-07-25 | 2,834 | — | $0 | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise | 2012-07-23 | 2012-07-25 | 2,601 | $46.34 | $120.5K | 116,669 | SEC↗ |
| ABT ABBOTT LABORATORIES | F Tax w/h | 2012-07-23 | 2012-07-25 | 4,334 | $65.06 | $282.0K | 115,169 | SEC↗ |
| ABT ABBOTT LABORATORIES | M Exercise | 2012-07-23 | 2012-07-25 | 2,834 | $51.28 | $145.3K | 119,503 | SEC↗ |
| ABT ABBOTT LABORATORIES | S Sale | 2012-03-20 | 2012-03-22 | 684 | $60.22 | $41.2K | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | S Sale | 2012-03-20 | 2012-03-22 | 140 | $60.22 | $8.4K | 0 | SEC↗ |
| ABT ABBOTT LABORATORIES | F Tax w/h | 2012-02-29 | 2012-03-02 | 8,868 | $57.04 | $505.8K | 115,272 | SEC↗ |
| ABT ABBOTT LABORATORIES | S Sale | 2012-02-29 | 2012-03-02 | 1,204 | $56.71 | $68.3K | 114,068 | SEC↗ |
| ABT ABBOTT LABORATORIES | A Award | 2012-02-29 | 2012-03-02 | 4,166 | — | $0 | 124,140 | SEC↗ |
| ABT ABBOTT LABORATORIES | A Award deriv | 2012-02-17 | 2012-02-22 | 48,100 | — | $0 | 48,100 | SEC↗ |
| ABT ABBOTT LABORATORIES | A Award | 2012-02-17 | 2012-02-22 | 26,700 | — | $0 | 119,974 | SEC↗ |